N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands
申请人:Leopoldo Marcello
公开号:US20070117811A1
公开(公告)日:2007-05-24
A series of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides was prepared and their affinity for serotonin 5-HT
7
, 5-HT
1A
, and 5-HT
2A
receptors was measured using in vitro binding assays. In relation to 5-HT
7
receptor affinity, receptor binding studies indicated that: (i) the optimal alkyl chain length was five methylenes; (ii) an unsubstituted 1,2,3,4-tetrahydronaphthalenyl nucleus was selected for further substitutions; and (iii) the substitution pattern of the aryl ring linked to the piperazine ring played a significant role. Several compound with high affinity for 5-HT
7
receptors were identified. Among them, 4-(2-methoxyphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (28), 4-(2-acetylphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (34), 4-(2-methylthiophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (44), 4-(2-hydroxyphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (46), 4-(2-methylphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (49) were assayed for the 5-HT
7
receptor mediated relaxation of substance P-induced guinea-pig ileum contraction. Compounds 28, 44, and 49 behaved as full agonists, compound 34 as a partial agonist, whereas derivative 46 acted as an antagonist.
一系列N-(1,2,3,4-四氢萘基)-4-芳基-1-哌嗪烷基酰胺被制备,并利用体外结合实验测定它们对5-HT7、5-HT1A和5-HT2A受体的亲和力。关于5-HT7受体亲和力,受体结合研究表明:(i) 最佳的烷基链长度为五个亚甲基;(ii) 选择未取代的1,2,3,4-四氢萘基核进行进一步取代;(iii) 与哌嗪环相连的芳基环的取代模式起着重要作用。鉴定了几种对5-HT7受体具有高亲和力的化合物。其中,4-(2-甲氧基苯基)-N-(1,2,3,4-四氢萘基)-1-哌嗪己酰胺(28)、4-(2-乙酰基苯基)-N-(1,2,3,4-四氢萘基)-1-哌嗪己酰胺(34)、4-(2-甲硫基苯基)-N-(1,2,3,4-四氢萘基)-1-哌嗪己酰胺(44)、4-(2-羟基苯基)-N-(1,2,3,4-四氢萘基)-1-哌嗪己酰胺(46)、4-(2-甲基苯基)-N-(1,2,3,4-四氢萘基)-1-哌嗪己酰胺(49)被用于评估对5-HT7受体介导的物质P诱导的豚鼠回肠收缩的松弛作用。化合物28、44和49表现为全激动剂,化合物34表现为部分激动剂,而衍生物46表现为拮抗剂。